Raffles Medical Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Raffles Medical Group hat ein durchschnittliches jährliches Gewinnwachstum von 17.7% verzeichnet, während die Branche Healthcare ein Gewinnwachstum gewachsen unter 15.1% jährlich einen Rückgang. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 10.8% pro Jahr. Raffles Medical Group's return on equity is 8.7%, und die Nettomargen betragen 12.7%.

Wichtige Informationen

17.7%

Wachstumsrate der Gewinne

16.9%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	9.7%
Wachstumsrate der Einnahmen	10.8%
Eigenkapitalrendite	8.7%
Netto-Marge	12.7%
Letzte Ertragsaktualisierung	31 Dec 2023

Jüngste Aktualisierungen vergangener Leistungen

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

May 09

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25

Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?

Apr 05

Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture

Mar 24

Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?

Mar 12

Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)

Feb 28

Insider Buying: The Raffles Medical Group Ltd (SGX:BSL) Executive Chairman & CEO Just Bought S$1.5m Worth Of Shares

Feb 24

What Is Raffles Medical Group Ltd's (SGX:BSL) Share Price Doing?

Feb 22

Aufschlüsselung der Einnahmen und Ausgaben

Wie Raffles Medical Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

SGX:BSL Einnahmen, Ausgaben und Erträge (SGD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Dec 23	708	90	142
30 Sep 23	747	117	123
30 Jun 23	730	144	0
31 Mar 23	749	144	3
31 Dec 22	825	143	110
30 Sep 22	808	124	62
30 Jun 22	791	104	13
31 Mar 22	758	94	10
31 Dec 21	725	84	7
30 Sep 21	698	86	7
30 Jun 21	671	88	7
31 Mar 21	619	77	7
31 Dec 20	568	66	7
30 Sep 20	541	60	9
30 Jun 20	508	50	8
31 Mar 20	514	55	9
31 Dec 19	522	60	10
30 Sep 19	514	63	14
30 Jun 19	504	66	16
31 Mar 19	497	69	15
31 Dec 18	489	71	20
30 Sep 18	484	71	18
30 Jun 18	483	71	17
31 Mar 18	483	71	16
31 Dec 17	478	71	15
30 Sep 17	473	70	16
30 Jun 17	473	70	16
31 Mar 17	472	70	16
31 Dec 16	474	70	16
30 Sep 16	470	71	16
30 Jun 16	452	71	15
31 Mar 16	432	70	14
31 Dec 15	411	69	13
30 Sep 15	396	69	11
30 Jun 15	389	68	11
31 Mar 15	382	68	10
31 Dec 14	375	68	10
30 Sep 14	363	89	9
30 Jun 14	353	87	9
31 Mar 14	347	86	9
31 Dec 13	341	85	9
30 Sep 13	336	62	8
30 Jun 13	330	61	8

Qualität der Erträge: BSL hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: BSLDie aktuellen Gewinnspannen (12.7%) sind niedriger als im letzten Jahr (17.4%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: BSLIn den letzten 5 Jahren sind die Gewinne von 17.7% jährlich gestiegen.

Beschleunigtes Wachstum: BSLDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: BSL hatte im vergangenen Jahr ein negatives Gewinnwachstum (-37.1%), was einen Vergleich mit dem Branchendurchschnitt Healthcare (-2%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: BSLDie Eigenkapitalrendite des Unternehmens (8.7%) wird als niedrig angesehen.

Raffles Medical Group Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Full year 2022 earnings: Revenues in line with analyst expectations

Full year 2022 earnings: EPS exceeds analyst expectations

Recent updates

Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024

Executive Chairman & CEO recently bought S$500k worth of stock

Upcoming dividend of S$0.024 per share

Raffles Medical Group Ltd Approves One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings: EPS misses analyst expectations

Now 20% undervalued

Raffles Medical Group Ltd Proposes Final Dividend for the Year Ended 31 December 2023, Payable on May 23, 2024

Price target decreased by 12% to S$1.14

Consensus EPS estimates fall by 21%

Executive Chairman & CEO recently bought S$3.6m worth of stock

Dividend of S$0.024 announced

Raffles Medical Group Ltd, Annual General Meeting, Apr 26, 2024

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Investor sentiment deteriorates as stock falls 15%

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Raffles Medical Group Ltd Announces Resignation of Soo Yu-Han Jessica as Joint Company Secretary, Effective 8 August 2023

High number of new directors

First half 2023 earnings released: EPS: S$0.032 (vs S$0.032 in 1H 2022)

Raffles Medical Group Ltd Announces Appointment of Lu Liangjian as Non-Executive and Non-Independent Director

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group Ltd to Report First Half, 2023 Results on Jul 31, 2023

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Upcoming dividend of S$0.038 per share at 2.6% yield

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Full year 2022 earnings: Revenues in line with analyst expectations

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Price target increased by 8.1% to S$1.72

Full year 2022 earnings: EPS exceeds analyst expectations

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Ltd to Report Fiscal Year 2022 Results on Feb 27, 2023

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Now 21% undervalued

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Now 21% undervalued

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Now 20% undervalued

Investor sentiment improved over the past week

Price target increased to S$1.52

Executive Chairman & CEO recently bought S$63k worth of stock

First half 2022 earnings released

Raffles Medical Group Ltd to Report First Half, 2022 Results on Aug 01, 2022

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Raffles Medical Group Ltd Approves Final Dividend for the Year Ended 31 December 2021

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Upcoming dividend of S$0.028 per share

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

Price target decreased to S$1.39

Raffles Medical Group Ltd Approves the Ordinary (One-Tier Tax Exempt) Core Dividend for the Financial Year Ended December 31, 2021, Payable on May 19, 2022

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Raffles Medical Group Ltd Proposes One-Tier Tax Exempt Final Dividend for the Year Ended 31 December 2021

Raffles Medical Group Ltd, Annual General Meeting, Apr 25, 2022

Executive Chairman & CEO recently bought S$595k worth of stock

Price target decreased to S$1.39

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Raffles Medical Group Ltd Proposes Special Dividend for the 2021